Results 111 to 120 of about 67,539 (292)

Fexofenadine is Efficacious and Safe in Children (Aged 6-11 Years) with Seasonal Allergic Rhinitis [PDF]

, 2003
Background: This is the first prospective, randomized, doubleblind, placebo-controlled study showing statistical improvement of an H1-antihistamine in children with seasonal allergic rhinitis in all symptoms throughout the entire treatment period ...
Bachert, C, Baena-Cagnani, C, Decosta, P, Finn, A, Hedlin, G, Kowalski, M, Meltzer, E, Potter, P, Rosado-Pinto, J, Ruuth, E, Scheinmann, P, Simons, F, Wahn, U   +12 more
core  

A survey on features of allergic rhinitis in children [PDF]

, 2013
Objective: A number of epidemiologic studies evaluated the prevalence of allergic rhinitis (AR), but few data are available on its different clinical presentations.
),, A. M., Zicari, C., Incorvaia, Caffarelli, Carlo, F., Frati, G., De Castro, I., Dell'Albani, L., Indinnimeo, M., Duse, M., Scolari, P., Puccinelli, Pediatric SURF Study, Group   +11 more
core   +1 more source

Exposures in Indoor Air Affecting Health

Allergy, EarlyView.
ABSTRACT Indoor air quality (IAQ) is influenced by a wide range of chemical, biological and physical agents that can negatively impact physical, immunological and mental health. Adverse health effects depend on the type and concentration of pollutants, duration of exposure, and individual susceptibility.
Maria Hartiala, Varpu Elenius, Alicia Aguado Pesquera, Silas Androulakis, Isabella Annesi‐Maesano, Artur Badyda, Sicco Brandsma, Ioanna Chatziprodromidou, Goran Gajski, Judith Garcia‐Aymerich, Chiara Giorio, Timo Hugg, Jouni J. K. Jaakkola, Sarah Koch, Pim E. G. Leonards, Angeliki Matrali, Lisa Melymuk, Natalie Mueller, Adam Muszyński, Jet Opbroek, Inês Paciência, Spyros N. Pandis, Sofya Pozdniakova, Aino K. Rantala, Sandra Rodríguez Sufuentes, Linda Schenk, Eva Sugeng, Adrià Sunyer‐Caldú, Apostolos Vantarakis, Alexander Zherebker, Ernesto Alfaro‐Moreno, Pernilla Bohlin Nizzetto, José Fermoso Dominguez, Stylianos Karatzas, Francesco Mureddu, Heidi Salonen, Nikolaos Papadopoulos, Tuomas Jartti, the IDEAL Consortium   +38 more
wiley   +1 more source

Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis

Allergology International, 2018
Background: The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis.
Kimihiro Okubo, Eiji Uchida, Takaaki Terahara, Katsuhiko Akiyama, Shigeo Kobayashi, Yusuke Tanaka   +5 more
doaj   +1 more source

Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series [PDF]

, 2000
OBJECTIVE: To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series.
Aitchison, T,, Llewellyn-Jones, R.H., McSharry, C., Reilly, D., Taylor, M.A.   +4 more
core   +2 more sources

EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention

Allergy, EarlyView.
ABSTRACT The allergy and asthma epidemic in urban societies following World War II is mostly caused by changes in the environment, diet and lifestyle. Disconnection of urban populations from the wider environment has reduced the protective factors building up immunological resilience.
Tari Haahtela, Liam O'Mahony, Claudia Traidl‐Hoffmann, Mubeccel Akdis, Ozlem Ceylan, Panagiotis Chaslaridis, Athanasios Damialis, Stefano Del Giacco, Antti Lauerma, Kari C. Nadeau, Inês Paciência, Isabella Pali‐Schöll, Oscar Palomares, Harald Renz, Jurgen Schwarze, Marilyn Urrutia‐Pereira, Carina Venter, Donata Vercelli, Tonya Winders, Cezmi A. Akdis, Marek Jutel, Ioana Agache   +21 more
wiley   +1 more source

At-a-glance - Pollens, climate and allergies: Quebec initiatives

Health Promotion and Chronic Disease Prevention in Canada, 2019
Pollen allergies are a major source of seasonal allergic rhinitis in North America. This type of rhinitis affects 17% of adults in Quebec, a marked increase in the last 30 years. Ragweed (Ambrosia artemisiifolia L.) pollens are responsible for 50% to 90%
Isabelle Demers, Pierre Gosselin
doaj   +1 more source

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

Exploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source

Epidemiology and burden of nasal congestion [PDF]

, 2010
Nasal congestion, which may be described as fullness, obstruction, reduced airflow, or being "stuffed up," is a commonly encountered symptom in clinical practice. Systematic study of congestion has largely considered it as a component of a disease state.
Ferguson, BJ, Fromer, L, Stewart, M
core   +3 more sources

Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III Trial

Allergy, EarlyView.
The RHAPSODY multinational study investigated 26 months of continuous treatment with 5‐grass‐pollen sublingual SLIT drops in adults with moderate‐to‐severe grass‐pollen‐induced allergic rhinoconjunctivitis. The primary efficacy endpoint (the average daily total combined score) showed statistically significant differences in favour of the active ...
Alain Didier, Ruta Gronskyte Juhl, Terrie Dalgaard, Antoine Chartier, Philippe Devillier   +4 more
wiley   +1 more source